Ophthalmic diseases Archives - GEN - Genetic Engineering and Biotechnology News

Home 2024

Switching Gene Therapy On and Off with a Pill

Genome Editing

Switching Gene Therapy On and Off with a Pill

Boosting Retinal Cell Protein Could Represent Therapeutic Approach Against AMD, Preclinical Study Suggests

Featured

Boosting Retinal Cell Protein Could Represent Therapeutic Approach Against AMD, Preclinical Study Suggests

Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space

Drug Discovery

Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space

ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop

Drug Discovery

ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop

CRISPR Enzyme Found in Metagenomic Study Is Tiny, Yet Active and Precise

Genome Editing

CRISPR Enzyme Found in Metagenomic Study Is Tiny, Yet Active and Precise

Gene Editing for Inherited Form of Blindness Shows Promise in Phase I/II Trial

Genome Editing

Gene Editing for Inherited Form of Blindness Shows Promise in Phase I/II Trial

StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting

Drug Discovery

StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting

Ascend Acquires GMP Manufacturing Capacity in Florida

Bioprocessing

Ascend Acquires GMP Manufacturing Capacity in Florida

REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III

Drug Discovery

REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III

Novel Thio-lipids Developed Capable of Reaching Eyes and Lungs in Animals

Infectious Diseases

Novel Thio-lipids Developed Capable of Reaching Eyes and Lungs in Animals

12 3...43 Page 1 of 43